6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone CAS 179688-29-0 Erlotinib Hydrochloride Waena Maʻemaʻe >99.0% (HPLC)
ʻO ka mea hana alakaʻi a me ka mea hoʻolako o Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-one CAS 179688-29-0
Please contact: alvin@ruifuchem.com
| Inoa Kimia | 6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-hoʻokahi |
| Nā huaʻōlelo like | 6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone;6,7-Bis(2-Methoxyethoxy)-3,4-Dihydroquinazolin-4-hoʻokahi;6,7-Bis(2-Methoxyethoxy)-4-Hydroxyquinazoline;6,7-Bis(2-Methoxyethoxy)-4-Quinazolinol;CP-380736 |
| haumia | Erlotinib haumia A;Erlotinib Lactam haumia |
| Helu CAS | 179688-29-0 |
| Helu CAT | RF2685 |
| Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
| ʻĀpana Molekala | C14H18N2O5 |
| Kaumaha Molecular | 294.31 |
| Lae hehee | 190.0 a i 194.0 ℃ |
| ʻO ka mānoanoa | 1.26±0.1 g/cm3 |
| Pilikino | Paʻi Lewa |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Pada keʻokeʻo a i ʻole keʻokeʻo |
| Maʻemaʻe / Kaʻina Hanana | >99.0% (HPLC) |
| Lae hehee | 190.0 a i 194.0 ℃ |
| Nalo ma ka maloo | <0.50% |
| Koena ma ka Ignition | <0.20% |
| Nā mea haumia pili e HPLC | |
| Ka haumia o ke kanaka | <0.50% |
| Huina paumaele | <1.00% |
| Nā Metala Kaumaha | <10ppm |
| Infrared Spectrum | Kūlike i ka hoʻolālā |
| Kūlana hoʻāʻo | Kūlana ʻoihana |
| Hoʻohana | Ka waena o Erlotinib Hydrochloride (CAS: 183319-69-9) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
Pehea e kūʻai ai?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 mau makahiki ʻike?Loaʻa iā mākou ma mua o 15 mau makahiki o ka ʻike i ka hana ʻana a me ka hoʻokuʻu ʻana aku i kahi ākea ākea o nā intermediates pharmaceutical kiʻekiʻe a i ʻole nā kemika maikaʻi.
Mākeke Nui?E kūʻai aku i ka mākeke kūloko, ʻAmelika ʻĀkau, ʻEulopa, India, Russia, Korea, Iapana, Australia, etc.
Nā pono?ʻO ke kūlana kiʻekiʻe, ke kumukūʻai kūpono, nā lawelawe ʻoihana a me ke kākoʻo ʻenehana, ka lawe wikiwiki ʻana.
ʻAno maikaʻiHōʻoiaʻiʻo?Pūnaehana hoʻomalu maikaʻi koʻikoʻi.ʻO nā lako ʻoihana no ka nānā ʻana ʻo NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Nā laʻana?Hāʻawi ka hapa nui o nā huahana i nā laʻana manuahi no ka loiloi maikaʻi, pono e uku ʻia ke kumukūʻai e nā mea kūʻai aku.
Hooia Hale Hana?Welina mai ka loiloi hale hana.E ʻoluʻolu e hoʻopaʻa manawa ma mua.
MOQ?ʻAʻohe MOQ.ʻAe ʻia ke kauoha liʻiliʻi.
Manawa Hoʻouna? Inā i loko o ka waihona, ʻekolu lā hoʻouna ʻia.
Kaʻahele?Ma ka Express (FedEx, DHL), ma ka Air, ma ke Kai.
Nā palapala?Ma hope o ka lawelawe kūʻai: COA, MOA, ROS, MSDS, etc.
Hoʻohui Kuʻuna?Hiki ke hāʻawi i nā lawelawe synthesis maʻamau e kūpono i kāu mau pono noiʻi.
Kūkākūkā uku?E hoʻouna mua ʻia ka invoice Proforma ma hope o ka hōʻoia ʻana o ke kauoha, hoʻopili ʻia kā mākou ʻike panakō.Uku e T/T (Telex Transfer), PayPal, Western Union, etc.
ʻO 6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-one (CAS: 179688-29-0) he mea waena o Erlotinib Hydrochloride (CAS: 183319-69-9).ʻO Erlotinib Hydrochlorate kahi mole liʻiliʻi tyrosine kinase inhibitor e hana hoʻohuli ʻia ma luna o nā epidermal growth factor receptors, he hydrochloride o erlotinib, kahi lāʻau i hoʻopaʻa ʻia i ka molecular.Ua ʻae ka US Food and Drug Administration (FDA) i ka erlotinib (Tarceva) i hui pū ʻia me ka gemcitabine ma ke ʻano he lāʻau lapaʻau mua no ka maʻi maʻi pancreatic kūloko a me ka metastatic.Hoʻohana nui ʻia ia ma ke ʻano he lāʻau lapaʻau ʻelua a ʻekolu paha no ka maʻi maʻi maʻi maʻi maʻi maʻi pancreatic a i ʻole metstatic non-small cell lung cancer (NSCLC).Hoʻohana ʻia ia e like me ka tyrosine inhibitor no ka mālama NSCLC.ʻO ka hui liʻiliʻi ʻo Erlotinib Hydrochlorate he tyrosine kinase receptor inhibitor ka mea e pale ai i ka hoʻonui ʻana o nā cell tumor ma ke kāohi ʻana i ka phosphorylation, e hoʻopaʻa ana i ka intracellular catalytic domain o tyrosine kinase i ka hoʻokūkū me ATP, no laila ke kāohi nei i ka transduction hōʻailona downstream a me ka pale ʻana i ka hana o ka ligand cell tumo. HER-1/EGFR.
